Stem cells “reprogrammed” by diabetes could increase heart attack risk

Diabetes has a long list of run-on health effects, and one of them is an increased risk of cardiovascular disease. Now, scientists at Oxford have uncovered a mechanism behind that, finding high blood sugar levels “reprogram” stem cells so the white blo… Continue reading Stem cells “reprogrammed” by diabetes could increase heart attack risk

“Shark cage” implant protects insulin-producing cells in diabetic mice

Researchers have found a way to maintain insulin levels in diabetic mice by growing and implanting new beta cells that produce the hormone. These cells are housed inside a tiny device that protects them from the animal’s immune system, like a shark cag… Continue reading “Shark cage” implant protects insulin-producing cells in diabetic mice

High blood pressure suggested as link between diabetes and dementia

New research has found diabetics who go on to develop dementia display higher blood pressure for years before cognitive decline appears, compared to diabetics who don't develop dementia

Researchers have long detected higher rates of dementia in people with type 2 diabetes. New findings from Imperial College London are offering clues to why that may be the case, indicating that cardiometabolic factors associated with diabetes, such as increased blood pressure, could be contributing to the development of dementia.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , , ,

Continue reading High blood pressure suggested as link between diabetes and dementia

Once-a-week insulin bolstered by results of phase 2 clinical trials

For millions of patients with diabetes, daily insulin injections are a necessary nuisance. A once-a-week shot might be more palatable, and new results from phase 2 clinical trials suggest just such a drug is safe and effective.Continue ReadingCategory:… Continue reading Once-a-week insulin bolstered by results of phase 2 clinical trials

Experimental oral pills auto-release insulin when glucose levels are high

Daily injections of insulin are a hassle for the hundreds of millions of people with diabetes. An oral pill would be much easier to swallow (pun intended), and now researchers from New York University Abu Dhabi have developed a new method for packing i… Continue reading Experimental oral pills auto-release insulin when glucose levels are high

Metastudy affirms low-carb diets can reverse type 2 diabetes

A new systematic review and meta-analysis published in the British Medical Journal has concluded adhering to a low-carbohydrate diet for six months is the most effective dietary strategy to put type type 2 diabetes into remission.Continue ReadingCatego… Continue reading Metastudy affirms low-carb diets can reverse type 2 diabetes

Self-adjusting insulin promises safer blood sugar control for diabetics

An incredible proof-of-concept study from a team of European scientists has demonstrated the development of a novel insulin molecule that can sense blood sugar levels and self-adjust its activity in response to a patient’s needs. The experimental molec… Continue reading Self-adjusting insulin promises safer blood sugar control for diabetics

Once-a-week insulin shot for type 2 diabetes passes Phase 2 trials

The promising results of a Phase 2 trial testing a new, once-weekly insulin treatment for type 2 diabetes have been published in The New England Journal of Medicine. The weekly injection was found to be as safe and effective as daily insulin shots and … Continue reading Once-a-week insulin shot for type 2 diabetes passes Phase 2 trials

Diabetes remission induced in mice through brain injections

Currently, the best treatments for type 2 diabetes involve managing blood sugar levels, but recent research suggests that the brain may be a new drug target for longer-term control. Now, a pair of studies on rats and mice has investigated how a certain… Continue reading Diabetes remission induced in mice through brain injections

Ultrafast-acting form of insulin developed by Stanford researchers

A team from Stanford University has developed an ultrafast-acting form of insulin that promises to work up to four times faster than current commercially available formulations. The novel drug has only been screened in animals so far but the researcher… Continue reading Ultrafast-acting form of insulin developed by Stanford researchers